Fukuoka, Kurume, Japan Clinical Trials

A listing of Fukuoka, Kurume, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 75 clinical trials
A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia Followed by an Open-label Extension Phase

A clinical study to investigate the effect of 2 doses of an investigational drug in acutely psychotic adult patients with schizophrenia. The study will consist of a double-blind phase followed by an open-label extension phase.

NHO Hizen Psychiatric Center
 (7.7 away) Contact site
  • 0 views
  • 11 Apr, 2021
  • +24 other locations
Evaluate the Safety and Tolerability for Nirsevimab in Immunocompromised Children

Study D5290C00008 is a Phase 2, open-label, uncontrolled, single-dose study to evaluate the safety and tolerability, PK, occurrence of ADA, and efficacy of nirsevimab in immunocompromised Japanese children who are 24 months of age at the time of dose administration. Approximately 30 subjects will be enrolled. Subjects will be followed …

methotrexate
wiskott-aldrich syndrome
corticosteroid therapy
tacrolimus
immunodeficiency
Research Site
 (0.6 away) Contact site
  • 15 views
  • 10 Jun, 2021
  • +7 other locations
An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease

This study is an extension study for participants with primary immunodeficiency disorders who were previously treated with IGSC, 20% in the TAK-664-3001 study. They must have completed that study or be about to complete it before joining this study. Participants will continue treatment with IGCS, 20% in this study. The …

Kurume University Hospital
 (0.6 away) Contact site
  • 0 views
  • 13 Jun, 2021
  • +7 other locations
A Study of MORAb-202 in Participants With Solid Tumors

The primary objective of this study is to evaluate the tolerability and safety profile of MORAb-202 in participants with solid tumors.

hormone therapy
endometrial carcinoma
solid tumor
endocrine therapy
cancer treatment
Eisai Trial Site 6
 (0.0 away) Contact site
  • 2 views
  • 26 Jan, 2021
  • +9 other locations
Study of Zanubrutinib in Japanese Participants With B-Cell Malignancies

This is a Phase 1/2 study of zanubrutinib in Japanese participants with mature B-cell malignancies. This study intends to assess the use of zanubrutinib as an investigational agent to develop new treatment options for Japanese participants with B-cell malignancies. No formal hypothesis testing will be performed given the small sample …

Kurume University Hospital
 (0.6 away) Contact site
  • 0 views
  • 01 Mar, 2021
  • +14 other locations
To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

Japanese patients with moderate or severe active ulcerative colitis as a subject when ozanimod 0.46 mg or 0.92 mg is orally administered is evaluated about dose response, efficacy and safety with placebo as a control.

hematochezia
endoscopy
sigmoidoscopy or colonoscopy
flexible sigmoidoscopy
Kurume University Hospital
 (0.6 away) Contact site
  • 26 views
  • 01 Feb, 2021
  • +57 other locations
Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma Phase III

The aim of this Phase III study is to evaluate the superiority of dose-dense temozolomide (ddTMZ) followed by bevacizumab at ddTMZ failure for glioblastoma at first recurrence or progression, comparing to bevacizumab alone.

astrocytoma
neutron capture therapy
bevacizumab
carmustine
recurrent disease
Kurume University Hospital
 (0.6 away) Contact site
  • 534 views
  • 26 Jan, 2021
  • +36 other locations
Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer

JCOG1801 is a randomized phase III trial which was initiated in Japan in August 2019 to confirm the superiority of preoperative chemoradiotherapy followed by surgery plus adjuvant chemotherapy for local relapse-free survival over standard treatment, i.e. surgery plus adjuvant chemotherapy, for previously non-irradiated locally recurrent rectal cancer.

adenocarcinoma
carcinoma
metastasis
measurable disease
platelet count
Kurume University School of Medicine
 (0.0 away) Contact site
  • 4 views
  • 25 Jan, 2021
  • +44 other locations
Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

This study will assess the use of risankizumab in adult patients with moderate to severe chronic plaque psoriasis and compare risankizumab to other commonly used biologics.

Kurume University Hospital /ID# 215034
 (0.6 away) Contact site
  • 93 views
  • 02 Feb, 2021
  • +286 other locations
Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

This is a multi-center observational study of atezolizumab combination therapy in patients with unresectable, advanced and recurrent non-small cell lung cancer(NSCLC) or extensive disease small cell lung cancer(ED-SCLC). 800 patients in NSCLC cohort and 400 patients in ED-SCLC cohort will be enrolled in this trial to assess the efficacy and …

Kurume University Hospital
 (0.6 away) Contact site
  • 0 views
  • 26 Jan, 2021
  • +72 other locations